Barclays’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $856K | Buy |
76,128
+28,712
| +61% | +$323K | ﹤0.01% | 2754 |
|
|
2025
Q1 | $270K | Sell |
47,416
-6,750
| -12% | -$38.4K | ﹤0.01% | 3179 |
|
|
2024
Q4 | $531K | Buy |
54,166
+42,224
| +354% | +$414K | ﹤0.01% | 3014 |
|
|
2024
Q3 | $98K | Buy |
11,942
+8,495
| +246% | +$69.7K | ﹤0.01% | 3753 |
|
|
2024
Q2 | $46K | Sell |
3,447
-6,227
| -64% | -$83.1K | ﹤0.01% | 3702 |
|
|
2024
Q1 | $448K | Buy |
9,674
+457
| +5% | +$21.2K | ﹤0.01% | 2902 |
|
|
2023
Q4 | $622K | Sell |
9,217
-166
| -2% | -$11.2K | ﹤0.01% | 2885 |
|
|
2023
Q3 | $678K | Buy |
9,383
+729
| +8% | +$52.7K | ﹤0.01% | 2355 |
|
|
2023
Q2 | $644K | Sell |
8,654
-11,001
| -56% | -$819K | ﹤0.01% | 2441 |
|
|
2023
Q1 | $1.05M | Sell |
19,655
-2,178
| -10% | -$116K | ﹤0.01% | 2108 |
|
|
2022
Q4 | $1.48M | Buy |
21,833
+2,754
| +14% | +$186K | ﹤0.01% | 1829 |
|
|
2022
Q3 | $2.38M | Buy |
19,079
+11,400
| +148% | +$1.42M | ﹤0.01% | 1539 |
|
|
2022
Q2 | $731K | Buy |
7,679
+6,693
| +679% | +$637K | ﹤0.01% | 2295 |
|
|
2022
Q1 | $159K | Buy |
+986
| New | +$159K | ﹤0.01% | 3447 |
|